PAX9 and neoplasm: Similarly, in a recent study on tumor-specific DNA methylation in ESCC cases from nine high-incidence countries, the top three prioritized genes (PAX9, SIM2, and THSD4) shared similar methylation differences in the discovery and replication sample sets.